These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 7673102

  • 21. [Efficacy of naltrexone in the treatment of alcohol dependence disorder in women].
    Ponce G, Sánchez-García J, Rubio G, Rodríguez-Jiménez R, Jiménez-Arriero MA, Palomo T.
    Actas Esp Psiquiatr; 2005; 33(1):13-8. PubMed ID: 15704026
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Opiates and alcohol self-administration in animals.
    Ulm RR, Volpicelli JR, Volpicelli LA.
    J Clin Psychiatry; 1995; 56 Suppl 7():5-14. PubMed ID: 7673105
    [Abstract] [Full Text] [Related]

  • 26. The effects of extended-release naltrexone on holiday drinking in alcohol-dependent patients.
    Lapham S, Forman R, Alexander M, Illeperuma A, Bohn MJ.
    J Subst Abuse Treat; 2009 Jan; 36(1):1-6. PubMed ID: 18775624
    [Abstract] [Full Text] [Related]

  • 27. Naltrexone for the treatment of obesity: review and update.
    Lee MW, Fujioka K.
    Expert Opin Pharmacother; 2009 Aug; 10(11):1841-5. PubMed ID: 19537999
    [Abstract] [Full Text] [Related]

  • 28. The effect of baclofen alone and in combination with naltrexone on ethanol consumption in the rat.
    Stromberg MF.
    Pharmacol Biochem Behav; 2004 Aug; 78(4):743-50. PubMed ID: 15301930
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes.
    Spanagel R, Zieglgänsberger W.
    Trends Pharmacol Sci; 1997 Feb; 18(2):54-9. PubMed ID: 9090311
    [Abstract] [Full Text] [Related]

  • 34. Activation of PPARγ by pioglitazone potentiates the effects of naltrexone on alcohol drinking and relapse in msP rats.
    Stopponi S, de Guglielmo G, Somaini L, Cippitelli A, Cannella N, Kallupi M, Ubaldi M, Heilig M, Demopulos G, Gaitanaris G, Ciccocioppo R.
    Alcohol Clin Exp Res; 2013 Aug; 37(8):1351-60. PubMed ID: 23550625
    [Abstract] [Full Text] [Related]

  • 35. Opioid Receptor Antagonists in the Treatment of Alcoholism.
    Serecigni JG.
    Adicciones; 2015 Sep 29; 27(3):214-30. PubMed ID: 26437315
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Pharmacological mechanisms of naltrexone and acamprosate in the prevention of relapse in alcohol dependence.
    Littleton J, Zieglgänsberger W.
    Am J Addict; 2003 Sep 29; 12(s1):s3-s11. PubMed ID: 14972776
    [Abstract] [Full Text] [Related]

  • 39. Predicting naltrexone response in alcohol-dependent patients: the contribution of functional magnetic resonance imaging.
    Mann K, Vollstädt-Klein S, Reinhard I, Leménager T, Fauth-Bühler M, Hermann D, Hoffmann S, Zimmermann US, Kiefer F, Heinz A, Smolka MN.
    Alcohol Clin Exp Res; 2014 Nov 29; 38(11):2754-62. PubMed ID: 25421512
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.